NM_000302.4(PLOD1):c.1865C>T (p.Pro622Leu) AND Cardiovascular phenotype

delete

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Oct 9, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000619594.2

Allele description

NM_000302.4(PLOD1):c.1865C>T (p.Pro622Leu)

Gene:

PLOD1:procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1p36.22

Genomic location:

Preferred name:

NM_000302.4(PLOD1):c.1865C>T (p.Pro622Leu)

HGVS:

NC_000001.11:g.11970779C>T
NG_008159.1:g.41091C>T
NM_000302.4:c.1865C>TMANE SELECT
NM_001316320.2:c.2006C>T
NP_000293.2:p.Pro622Leu
NP_001303249.1:p.Pro669Leu
NC_000001.10:g.12030836C>T
NM_000302.3:c.1865C>T

Protein change:

P622L

Links:

dbSNP: rs766973023

NCBI 1000 Genomes Browser:

rs766973023

Molecular consequence:

NM_000302.4:c.1865C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001316320.2:c.2006C>T - missense variant - [Sequence Ontology: SO:0001583]

Observations:

Condition(s)

Name:: Cardiovascular phenotype
Identifiers:: MedGen: CN230736

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000739535	Ambry Genetics	criteria provided, single submitter (Ambry Autosomal Dominant and X-Linked criteria (7/2020))	Uncertain significance (Oct 9, 2020)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000739535

Ambry Genetics

criteria provided, single submitter

(Ambry Autosomal Dominant and X-Linked criteria (7/2020))

Uncertain significance
(Oct 9, 2020)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	1	not provided	not provided	1	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV000739535.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

Description

The p.P622L variant (also known as c.1865C>T), located in coding exon 17 of the PLOD1 gene, results from a C to T substitution at nucleotide position 1865. The proline at codon 622 is replaced by leucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	1	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Nov 5, 2022

ClinVar

Relating variation to medicine